Unlock stock picks and a broker-level newsfeed that powers Wall Street.
90.29
-0.77
(-0.85%)
At close: 4:00:01 PM EDT
90.29
0.00
(0.00%)
After hours: 4:05:09 PM EDT
Research Analysis
Earnings Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 19 | 18 |
| Avg. Estimate | -2.02 | -2.45 | -4.93 | -3.94 |
| Low Estimate | -2.86 | -3.59 | -7.92 | -8.75 |
| High Estimate | -1.24 | -1.22 | -2.31 | -0.38 |
| Year Ago EPS | -1.31 | -3.36 | -2.77 | -4.93 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 19 | 18 |
| Avg. Estimate | 159.6M | 137.4M | 2.12B | 2.37B |
| Low Estimate | 89M | 67.93M | 1.8B | 1.66B |
| High Estimate | 266.4M | 406.4M | 2.73B | 3.54B |
| Year Ago Sales | 187.6M | 128.7M | 2.75B | 2.12B |
| Sales Growth (year/est) | -14.92% | 6.76% | -22.77% | 11.37% |
Earnings History
| Currency in EUR | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.35 | -2.04 | -1.61 | 0.37 |
| EPS Actual | -1.31 | -3.36 | 0.81 | 1.08 |
| Difference | 0.04 | -1.32 | 2.42 | 0.71 |
| Surprise % | 2.86% | -64.44% | 150.43% | 188.88% |
EPS Trend
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -2.02 | -2.45 | -4.93 | -3.94 |
| 7 Days Ago | -2.05 | -2.47 | -4.92 | -3.95 |
| 30 Days Ago | -2.07 | -2.47 | -3.42 | -3.5 |
| 60 Days Ago | -1.97 | -2.36 | -3.38 | -3.5 |
| 90 Days Ago | -1.89 | -2.28 | -3.34 | -3.44 |
EPS Revisions
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 2 |
| Up Last 30 Days | 3 | 3 | 3 | 4 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 11 | 9 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BNTX | -53.93% | 27.09% | -77.84% | 19.93% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Initiated | Citigroup: Buy | 3/13/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 3/11/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 3/11/2025 |
| Maintains | BMO Capital: Outperform to Outperform | 3/11/2025 |
| Initiated | Truist Securities: Buy | 1/10/2025 |
Related Tickers
NVAX Novavax, Inc.
6.00
-6.40%
MRNA Moderna, Inc.
27.16
-4.20%
PCVX Vaxcyte, Inc.
32.23
-14.65%
CVAC CureVac N.V.
2.7200
-1.81%
REGN Regeneron Pharmaceuticals, Inc.
617.00
-2.72%
SRPT Sarepta Therapeutics, Inc.
61.91
-2.99%
CRSP CRISPR Therapeutics AG
33.14
-2.62%
VRTX Vertex Pharmaceuticals Incorporated
484.74
-0.02%
ALNY Alnylam Pharmaceuticals, Inc.
255.76
-5.28%
NTLA Intellia Therapeutics, Inc.
6.66
-6.40%